Shares of biopharmaceutical company MediWound Ltd. (MDWD) were down more than 12 percent in pre-market on Monday to $18.60, after announcing private placement of 1.45 million shares at $17.20 per share.
The company has entered into share purchase agreement with several new and existing investors, including Molnlycke Health Care, a MedTech company specializing in solutions for wound care and surgical procedures.
MediWound intends to use the gross proceeds from the private investment in public equity or PIPE offering of $25 million to advance EscharEx pre-commercial activities, accelerate the development of large-scale manufacturing capabilities specifically for EscharEx, and for general corporate purposes.
MediWound shares had closed at $21.16, up 5.27 percent on Friday. The stock has traded in the range of $7.10 - $24.00 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.